Aravind Palraj / X
Jul 22, 2025, 09:17
Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
Aravind Palraj, MD highlights a crucial message on his X page:
”Antiphospholipid antibodies (aPL) are key to diagnosing APS—but timing, type, and persistence matter.
Triple positive? Highest thrombosis risk.
Test smart. Interpret wisely.”
Want to dive deeper into Antiphospholipid Syndrome?
On Hemostasis Today, you can explore in-depth, clinically relevant, and first-hand academic knowledge on:
- Diagnostic strategies for APS
- Role of Lupus Anticoagulant, anticardiolipin, and β2-GPI antibodies
- Risk stratification and management approaches in triple-positive patients
- Anticoagulation dilemmas in APS
-
Apr 25, 2026, 11:44Ruiming Li: Why the COMBO Plus form is a Masterclass in Vascular Repair
-
Apr 25, 2026, 11:19Nathan Connell: Bleeding Risk Is Not Limited to Delivery
-
Apr 25, 2026, 11:14Rashad Mohamed: What Does ‘Capping’ Mean in Anticoagulant Dosing?
-
Apr 25, 2026, 11:07Anne de Vaan: The Results of the PRIDES Study Are Now Available
-
Apr 25, 2026, 10:50Flora Peyvandi: Proteomic Insights of Relapse Risk in Thrombotic Thrombocytopenic Purpura
-
Apr 25, 2026, 10:40Kalyan Roy: Effect of Irradiation on Red Blood Cells
-
Apr 25, 2026, 10:38David Sinclair: How are High Omega-3 Levels Linked to Low Mortality Risk
-
Apr 25, 2026, 10:26Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
-
Apr 25, 2026, 10:05Lutz Knabe: One Child’s Journey from Pain to Hope Beyond Severe Bleeding Disorder